Inclusion Criteria:~A patient is eligible for the study if all of the following apply:~1. With either gender
aged at least 40 years old~2. With a diagnosis of one of the following disease i. Vascular dementia according
to the NINDS-AIREN International Workshop criteria or ii. Alzheimer's disease according to the NIAAA criteria
iii. Mixed dementia (possible Alzheimer's disease with cerebrovascular disease) according to the NIAAA
criteria~ Note:~ 1. NINDS-AIREN: National Institute of Neurological Disorders and Stroke and Association
Internationale pour la Recherche et l'Enseignement en Neurosciences~ 2. NIAAA: National Institute on
Aging-Alzheimer's Association~3. With mild-to-moderate dementia (score of the Mini-Mental State Examination
(MMSE) defined as between 10 to 24)~4. Able to read, write, communicate, and understand cognitive testing
instructions~5. Having a responsible caregiver who spends adequate time daily with the patient; the caregiver
will accompany the patient to all clinic visits during the study and supervise all study dosing requirements
and concomitant medications~6. Signed, by patients and the responsible caregiver, the written informed consent
form~
